NEGRINI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 32.328
AS - Asia 16.521
EU - Europa 11.999
SA - Sud America 2.432
AF - Africa 366
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 14
Totale 63.700
Nazione #
US - Stati Uniti d'America 31.666
SG - Singapore 6.355
CN - Cina 4.064
FI - Finlandia 2.724
IT - Italia 2.055
DE - Germania 1.949
BR - Brasile 1.835
VN - Vietnam 1.801
UA - Ucraina 1.386
HK - Hong Kong 1.345
GB - Regno Unito 995
TR - Turchia 979
PL - Polonia 623
FR - Francia 525
SE - Svezia 491
RU - Federazione Russa 403
BD - Bangladesh 363
JP - Giappone 358
IN - India 354
CA - Canada 316
MX - Messico 264
ID - Indonesia 232
AR - Argentina 230
NL - Olanda 180
ZA - Sudafrica 126
BE - Belgio 115
ES - Italia 112
IQ - Iraq 106
PK - Pakistan 89
AT - Austria 86
EC - Ecuador 84
CZ - Repubblica Ceca 74
CO - Colombia 68
VE - Venezuela 63
LT - Lituania 60
SA - Arabia Saudita 57
UZ - Uzbekistan 55
CL - Cile 48
RO - Romania 45
PH - Filippine 43
MA - Marocco 40
TN - Tunisia 39
MY - Malesia 38
AU - Australia 35
AE - Emirati Arabi Uniti 34
EG - Egitto 33
IR - Iran 31
JO - Giordania 30
KE - Kenya 30
PY - Paraguay 29
CH - Svizzera 27
IE - Irlanda 27
BO - Bolivia 25
UY - Uruguay 25
DZ - Algeria 22
IL - Israele 20
KR - Corea 20
OM - Oman 19
PE - Perù 19
LB - Libano 17
NP - Nepal 17
JM - Giamaica 16
ET - Etiopia 15
DO - Repubblica Dominicana 14
GR - Grecia 14
TH - Thailandia 14
AL - Albania 13
KZ - Kazakistan 11
LV - Lettonia 11
NG - Nigeria 11
RS - Serbia 11
AZ - Azerbaigian 10
CR - Costa Rica 10
HR - Croazia 10
DK - Danimarca 9
HN - Honduras 9
SN - Senegal 9
BG - Bulgaria 8
EU - Europa 8
PA - Panama 8
PT - Portogallo 8
CI - Costa d'Avorio 7
HU - Ungheria 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
PS - Palestinian Territory 6
LY - Libia 5
MD - Moldavia 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
AM - Armenia 4
AO - Angola 4
EE - Estonia 4
KH - Cambogia 4
MU - Mauritius 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
Totale 63.614
Città #
Singapore 3.939
Ashburn 3.657
Fairfield 2.944
Woodbridge 2.756
Helsinki 2.245
San Jose 2.153
Houston 1.908
Chandler 1.549
Jacksonville 1.510
Hong Kong 1.306
Beijing 1.280
Santa Clara 1.258
Ann Arbor 1.189
Seattle 1.105
Wilmington 1.031
Cambridge 904
Munich 753
New York 679
Warsaw 607
Ho Chi Minh City 585
Izmir 563
Los Angeles 543
Dallas 479
Nanjing 467
Hanoi 397
Ferrara 393
Princeton 346
Tokyo 339
Lauterbourg 297
San Diego 275
Milan 269
Boardman 250
Shanghai 220
São Paulo 193
Orem 169
Mexico City 164
Council Bluffs 160
Jakarta 159
Turku 158
London 150
Nanchang 140
Shenyang 131
Tianjin 121
Buffalo 118
Montreal 115
Hefei 113
Bremen 110
Chicago 109
Brooklyn 107
Brussels 106
Denver 104
Dearborn 103
Atlanta 94
Rome 92
Addison 90
Falls Church 87
Chennai 86
The Dalles 85
Johannesburg 84
Changsha 83
Dong Ket 81
Toronto 81
Amsterdam 80
Da Nang 79
Bologna 77
Stockholm 74
Phoenix 73
Poplar 73
Frankfurt am Main 71
Haiphong 71
Hebei 71
Moscow 69
Jiaxing 68
Rio de Janeiro 66
Jinan 65
Guangzhou 61
Manchester 61
Mountain View 61
Boston 60
San Francisco 60
Falkenstein 57
Nuremberg 56
San Mateo 56
Washington 56
Kunming 55
Mumbai 49
Ankara 48
Redwood City 48
Brno 46
Norwalk 46
Tashkent 46
Vienna 45
Zhengzhou 44
Ningbo 43
Columbus 41
Hangzhou 41
Baghdad 38
Philadelphia 37
Auburn Hills 34
Augusta 33
Totale 43.748
Nome #
An in vitro method for the diagnosis of neoplastic diseases by methylation analysis of the CDH4 gene, oligonucleotides and kits useful in such method 2.037
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 663
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 403
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 371
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 361
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 337
Absolute quantification of cell-free microRNAs in cancer patients 333
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 323
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 318
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 315
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 312
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 303
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 302
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 301
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 301
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 298
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 297
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 291
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 286
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 283
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 276
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 274
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 272
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 270
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 268
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 268
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 266
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 264
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 263
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 262
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 256
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 256
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 254
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 253
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 251
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 249
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 249
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 249
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 248
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 248
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 246
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 244
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 243
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 243
BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors 242
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 241
Circulating non-coding RNA as biomarkers in colorectal cancer 238
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 238
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 237
MicroRNA involvement in hepatocellular carcinoma 236
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 236
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 234
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 233
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 233
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 232
MicroRNA e cancro 232
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 231
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 230
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 230
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 228
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 226
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 226
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 226
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 224
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 223
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 222
Reprogramming of miRNA networks in cancer and leukemia 221
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 221
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 221
Analysis of MLH1 promoter methylation in colorectal carcinomas with microsatellite instability 220
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 220
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 219
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 218
A microRNA signature of hypoxia 218
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 218
Animal Models of Hepatocellular Carcinoma Prevention 217
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 217
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 216
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 215
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 214
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 214
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 214
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 212
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 210
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 210
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 210
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 209
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 209
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 208
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 207
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. In: POLYOMAVIRUSES AND HUMAN DISEASES 207
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 207
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma 207
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 207
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 206
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 205
Characterization of a 4-Mb region at chromosome 6q21 harboring a replicative senescence gene 204
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 202
Simian virus 40 infection in humans and association with human diseases: results and hypotheses 201
Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor 201
Totale 26.910
Categoria #
all - tutte 267.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.725
Totale 278.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 0 0 0 0 0 0 362
2021/20223.752 139 356 300 169 193 188 217 219 122 271 360 1.218
2022/20233.610 390 233 128 466 604 522 162 301 454 32 189 129
2023/20242.169 187 245 95 58 169 498 112 186 44 42 59 474
2024/20258.797 188 179 650 350 1.005 859 481 499 1.606 794 1.223 963
2025/202624.918 2.253 909 1.871 2.968 3.333 1.545 2.989 1.292 4.185 2.341 1.079 153
Totale 64.224